Treatment of intrabony periodontal defects using rhFGF‐2 in combination with deproteinized bovine bone mineral or rhFGF‐2 alone: A 6‐month randomized controlled trial

AIM: To evaluate the use of recombinant human fibroblast growth factor (rhFGF)‐2 in combination with deproteinized bovine bone mineral (DBBM) compared with rhFGF‐2 alone, in the treatment of intrabony periodontal defects. MATERIALS AND METHODS: Patients with periodontitis who had received initial pe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Periodontol
Prif Awduron: Saito, Atsushi, Bizenjima, Takahiro, Takeuchi, Takahiro, Suzuki, Eiichi, Sato, Masahiro, Yoshikawa, Kouki, Kitamura, Yurie, Matsugami, Daisuke, Aoki, Hideto, Kita, Daichi, Imamura, Kentaro, Irokawa, Daisuke, Seshima, Fumi, Tomita, Sachiyo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2019
Pynciau:
Periodontal Therapy
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899590/
https://ncbi.nlm.nih.gov/pubmed/30758076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpe.13086
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg